Imfinzi 500 MG/10 ML vial 10ML
Ended Awarded Last action
- Contract number
- SPE2DR26F20DS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,889
Award facts
- Contract value 100% obligated
- $23,889.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 2, 2026, for the supply of IMFINZI 500 mg/10 mL vials totaling $23,889.28, with completion scheduled for January 26, 2026. This is a firm fixed price delivery order with no set-aside designation, issued under open competition, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. IMFINZI (durvalumab) is a checkpoint inhibitor immunotherapy used in oncology treatment, indicating this order supports military and federal healthcare pharmaceutical supply needs.
This delivery order is a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp leverages this comprehensive contract vehicle to supply a broad range of pharmaceutical products, medical supplies, vaccines, and specialty medications to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems globally. The company's consistent award history through competitive procurement demonstrates its capability to fulfill diverse federal medical supply requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F20DS?
SPE2DR26F20DS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 2, 2026.
How much is contract SPE2DR26F20DS worth?
The government has obligated $23,889 on SPE2DR26F20DS.
Is contract SPE2DR26F20DS an order under another contract?
Yes. SPE2DR26F20DS is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F20DS competed?
The extent of competition for SPE2DR26F20DS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award